A detailed history of Tls Advisors LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Tls Advisors LLC holds 771,531 shares of OVID stock, worth $817,822. This represents 1.92% of its overall portfolio holdings.

Number of Shares
771,531
Previous 1,125,296 31.44%
Holding current value
$817,822
Previous $866,000 5.08%
% of portfolio
1.92%
Previous 2.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.75 - $1.3 $265,323 - $459,894
-353,765 Reduced 31.44%
771,531 $910,000
Q2 2024

Aug 07, 2024

SELL
$0.7 - $3.34 $136,068 - $649,239
-194,383 Reduced 14.73%
1,125,296 $866,000
Q2 2023

Nov 15, 2023

SELL
$2.53 - $3.89 $153,487 - $235,994
-60,667 Reduced 4.4%
1,319,679 $4.33 Million
Q1 2023

Nov 15, 2023

SELL
$1.88 - $2.85 $207,153 - $314,035
-110,188 Reduced 7.39%
1,380,346 $3.52 Million
Q4 2022

Feb 14, 2023

BUY
$1.43 - $1.89 $2.13 Million - $2.82 Million
1,490,534 New
1,490,534 $2.77 Million

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $74.6M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Tls Advisors LLC Portfolio

Follow Tls Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tls Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tls Advisors LLC with notifications on news.